Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized, double-blind, vehicle-controlled trial of Amphotericin B oral gel vs Ampho-Moronal suspension in oropharyngeal candidiasis
2013-000371-32Phase 3Completed
- Sponsor
- Dermapharm
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of amphotericin b in oral candidiasis (3 arms), sponsored by Dermapharm. Primary endpoint: Success rate at end of treatment (Day 14). Started Jul 2014; status: completed.
02
Drugs
amphotericin b
03
Conditions
oral candidiasis
Beyond the preview
Go deeper on 2013-000371-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000371-32.